EMA — authorised 23 August 2018
- Marketing authorisation holder: ULTRAGENYX PHARM INC
- Status: approved
🇪🇺 Mepsevii in European Union
EMA authorised Mepsevii on 23 August 2018
Marketing authorisation
Mepsevii in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in European Union
Frequently asked questions
Is Mepsevii approved in European Union?
Yes. EMA authorised it on 23 August 2018.
Who is the marketing authorisation holder for Mepsevii in European Union?
ULTRAGENYX PHARM INC holds the EU marketing authorisation.